Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
2013 · Cellular and Molecular Life Sciences · 93 citations
https://doi.org/10.1007/s00018-013-1480-4
F
Federica Rizzo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
50
Papers
1.7K
Citations
21
h-index
25
i10-index
Federica Rizzo is an academic researcher from University of Milan. The author has contributed to research in topics: Neurogenetic and Muscular Disorders Research & Amyotrophic Lateral Sclerosis Research & Hereditary Neurological Disorders. The author has an h-index of 21, co-authored 43 publications.
ORCID: 0000-0002-7677-0330Papers by this author
worksSynaptotagmin 13 is neuroprotective across motor neuron diseases
2020 · Acta Neuropathologica · 55 citations
https://doi.org/10.1007/s00401-020-02133-x
Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype
2016 · Scientific Reports · 32 citations
https://doi.org/10.1038/srep21301
Genome-wide RNA-seq of iPSC-derived motor neurons indicates selective cytoskeletal perturbation in Brown–Vialetto disease that is partially rescued by riboflavin
2017 · Scientific Reports · 29 citations
https://doi.org/10.1038/srep46271
Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot–Marie–Tooth type 2A
2023 · Cellular and Molecular Life Sciences · 19 citations
https://doi.org/10.1007/s00018-023-05018-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat